Nope, it ended up being the reverse. Croda IS the mammoth deal and anyone not realising just how big the potential needs to take a look at their client list of who's who within the skin cosmetics industry.
Scientific validation Commercial validation Access to 12000 + Croda clients Access to some of the biggest names in cosmetics Option to buy lysate at a reduced cost Significant investment in production c1 year to complete production 9 months of testing already complete Fully funded for 3 years for all existing programs
I have it on good authority there is NO BORROW available to short OPTI and never has been. SB is different of course. The ability to short OPTI is a myth which ranks right up there with me being a 6 ft tall dark and handsome and a playboy lifestyle.
The problem you and I have is knowledge of what is developing behind the scenes. SOH has previously discussed investment opportunities; note the £250k raised via SBTX earlier.
You are right in what you say via TWs podcast a few weeks ago....the cash position was as such it was sufficient with "existing plans." We now know these plans have expanded into new and rather large opportunities, potentially across 4 retailers in the UK and USA. These are a mix of OPTI home brands and retailer home brands. There former will need investment from OPTI to stock stores, plus cash for the ad campaign.
Also, IF OPTI are seeking NASDAQ listing, funds for this will also be needed.
SOH had a meeting with NOMAD, et al, regarding RNSing commercial agreements that will not generate revenues until a future appointed time as not being material to move the share price, as can be testified over the majority.
History makes clear each new agreement sees MMs mark up the SP by 1.5-2p even before a trade, then its sold into, so whats the point? It serves the traders not investors.
Going forward, we may get existing partner updates and home brand updates because these appear to be early revenue drivers, so will need to be announced. IMHO, nothing official yet, but does appears to be the case, though October is traditionally a quiet month.
I have had 3 so far and the wife has had a couple. We are in agreement blueberry/raspberry are now a favourite flapjack. In my opinion, they seem marginally more moist than the cranberry/coconut we currently have and the texture also seemed a little smoother. We very much like these and will most certainly be ordering them when available.
I also gave limited feedback on the flavour boosts We are struggling to get the water to flavour boost ratio right. These are much sweeter than we expected. Thus far, we have only used them in tap water and Buxton spring. We notice the tap water tasted cleaner and smoother. Our water isn't too hard, but we did notice an improvement.
SOH Thanks – consistent with my views. I appreciate your feedback. Feel free to share with investors.
They are designed to be more mainstream being a retail offering in a major supermarket and are slighter sweeter due to the berries and have more moisture making the texture better. They are produced by our existing manufacturer and given the projected volumes will lead to a big reduction in unit costs.
The idea of the flavours was to supplement existing or new products – such as the shakes. We also have an unflavoured version of SlimBiome Medical going through registration for CE marking which will link with the flavours. We have other flavour suppliers and flavours but wanted to test the market with these first.
Yes, indeed. Although LP-LDL is phase 3 ready it appears the US pharma is using LP-LDL in a combo of its own, hence why they talk of phase 1. There have been two high profile cholesterol failure by big phama's in recent years. Merks and Pfizer, if my old grey recalls. Both curbed their attempts for a pharma based cholesterol drug.